Showing results (41-50 of 149) with videos related to

Sort By:
Pageof 15
The Oncologist|March 5, 2025
Benefit of adjuvant chemotherapy for T1cN0M0 and selected T1bN0M0 triple-negative breast cancer: a nationwide cancer registry-based studyChiao Lo, Dwan-Ying Chang, Yen-Shen Lu, et al.
The Journal of Biological Chemistry|March 6, 2009
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathwayKuen-Feng Chen, Pei-Yen Yeh, Chiun Hsu, et al.
Cell Reports|January 2, 2024
Genetic insights into carbohydrate sulfotransferase 8 and its impact on the immunotherapy efficacy of cancerWen-Cheng Chou, Wei-Ting Chen, Chun-Tse Kuo, et al.
Journal of Neuro-Oncology|April 30, 2020
Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survivalTom Wei-Wu Chen, I-Shiow Jan, Dwang-Ying Chang, et al.
Cancer|August 18, 2010
The prevalence and assessment of ErbB2-positive breast cancer in Asia: a literature surveyYew Oo Tan, Sehwan Han, Yen-Shen Lu, et al.
Journal of Neuro-Oncology|July 3, 2013
Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomasPei-Fang Wu, Wen-Chang Huang, James Chih-Hsin Yang, et al.
Anticancer Research|March 14, 2007
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancerChia-Chi Lin, Ann-Lii Cheng, Chih-Hung Hsu, et al.
Hepato-Gastroenterology|May 18, 2004
Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinomaYen-Shen Lu, Chiun Hsu, Chi-Cheng Li, et al.
The Lancet. Oncology|November 3, 2009
Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009Nan Soon Wong, Benjamin O Anderson, Kei Siong Khoo, et al.
BMC Cancer|December 28, 2012
Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapyYu-Hsuan Kuo, Ching-Hung Lin, Wen-Yi Shau, et al.
Pageof 15